Nordic Life Science days 2017
Ectin Research will be represented by Anna Sjöblom-Hallén at the Nordic Life Science (NLS) days in Malmö the…
Read moreEctin Research will be represented by Anna Sjöblom-Hallén at the Nordic Life Science (NLS) days in Malmö the…
Read moreEuropean patent office (EPO) has granted the patent application regarding the company technology and the patent has now…
Read moreEctin research second issue of shares amounting to a value of 1.5 million SEK was completed in July…
Read moreEctin Research has been selected by the European Commission as the winner of HORIZON 2020 “Phase 1” –…
Read moreThe company was recently granted additional “Såddfinansiering” to support the development of bladder cancer therapy.
Read moreMeet the company at BIO-Europe, one of the main events for partnering and drug development, this year in…
Read moreVINNOVA through Sahlgrenska Science Park supports Ectin Research business developmental activities by rewarding the company 100 000 SEK…
Read moreNext phase of product development of MFA-370 against severe bladder cancer is initiated by Ectin research. An experienced…
Read moreEctin research first issue of shares amounting to a value of 3 million SEK is completed and the…
Read moreThe company announces the appointment of Michael Oredsson as chairman of Ectin Research. He is currently CEO of…
Read more